A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast)

Marit Ahrens, Bernard Escudier, Ekaterini Boleti, Marc-Oliver Grimm, Marine Gross Goupir, Pilippe Barthelemy, Gwenaelle Gravis, Jens Bedekes, Philipp Ivanyi, Andrej Panic, Stefanie Zschaebitz, Sylvie Neyrieru, Begona Mellado, Anika Biel, Tom Wadell, Jose Pablo Maroto, Margitta Retz, Martin Boegemann, Sylvie Rottey, John HaanenSjoukje Oosting, Daniel Castellano, Arndt Hartmann, Lothar Bergmann

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)226-226
Number of pages1
JournalOncology Research and Treatment
Volume43
Publication statusPublished - Feb-2020

Cite this